N@N

Inhibitex to Host Conference Call to Report Third Quarter Financial Results on November 9, 2010

_{//health-fitness.news-articles.net/content/2010/ .. uarter-financial-results-on-november-9-2010.html}
^{Published in Health and Fitness on Friday, October 29th 2010 at 12:35 GMT by Market Wire}  

ATLANTA--([ BUSINESS WIRE ])--Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host a conference call on Tuesday, November 9, 2010 at 9:00 a.m. EST to review the Companya™s third quarter financial results and provide an update on recent corporate developments. The Company will issue a press release regarding its financial results on the same day, prior to the conference call.

Webcast Information

To access the conference call, please dial (877) 407-9210 (domestic) or (201) 689-8049 (international). A replay of the call will be available from 11:00 a.m. Eastern Standard Time on November 9^th until December 10, 2010 at midnight. To access the replay, please dial (877) 660-6853 (domestic) or (201) 612-7415 (international) and reference the account # 286 and the conference id # 359917. A live audio webcast of the call and the archived webcast will be available in the News and Events section of the Inhibitex website at [ http://www.inhibitex.com ].

About Inhibitex

Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a biopharmaceutical company focused on developing products to prevent and treat serious infectious diseases. The Companya™s pipeline includes FV-100, which is in Phase II clinical development for the treatment of shingles, and INX-189, a nucleotide polymerase inhibitor in Phase 1 clinical development for the treatment of chronic hepatitis C infections. The Company also has additional HCV nucleotide polymerase inhibitors in preclinical development and has licensed the use of its proprietary MSCRAMM^® protein platform to Pfizer for the development of staphylococcal vaccines.

For additional information about the Company, please visit [ www.inhibitex.com ].